Megharani Mahajan

4PUBLICATIONS
27CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 30, 2025
The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer.

Megharani Mahajan, Alondra L Rodriguez Sanchez, Sridharan Jayamohan

|Sep 11, 2024
PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma.

Khaled Mohamed Nassar, Xue Yang, Adriana Baker

|Feb 10, 2024
Novel LIPA-Targeted Therapy for Treating Ovarian Cancer.

Alexia B Collier, Suryavathi Viswanadhapalli, Rahul Gopalam

Pageof 1